US 11434300
Methods and antibody compositions for tumor treatment
granted A61KA61K2039/505A61P
Quick answer
US patent 11434300 (Methods and antibody compositions for tumor treatment) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61P, A61P17/00, A61P35/00